You are here: Infothek - Blood Pressure Medications - Other Medications for Hypertension Treatment

Other Medications for Hypertension Treatment

If it is not possible to adequately control the blood pressure despite multiple combination treatments (triple combo) or due to side effects that lead to discontinuation of medication, the current guidelines recommend adding a mineralocorticoid receptor antagonist or another diuretic, or adding an alpha blocker or beta blocker (this should also be considered during previous therapy stages if appropriate).

Alpha Blockers

These medications primarily act on the alpha-1 receptors and block the effects of adrenaline and noradrenaline. Alpha-1 receptors are mainly found in smooth muscle cells, including in blood vessels and the urinary tract. They cause vasodilation and thus lower blood pressure. They are also prescribed for benign prostatic hyperplasia.
Some beta blockers also have an additional alpha-blocking effect, e.g., Carvedilol.

Side Effects:
Infections of the respiratory and urinary tracts are common with Doxazosin. Symptoms such as headaches, rapid heartbeat, and palpitations, as well as gastrointestinal discomfort, are also observed under this medication.
Please refer to the manufacturer's package insert for additional side effects.

Active Ingredients: Doxazosin (Doxacor, Doxagamma, etc.), Urapidil (Ebrantil, Urapidil)

Renin Inhibitors

Mechanism of Action of Renin Inhibitors for Blood Pressure Reduction

Renin Inhibitors: Effect

A renin inhibitor acts relatively early in the renin-angiotensin-aldosterone system. It inhibits the conversion of angiotensinogen to angiotensin I by the enzyme renin.

Renin Inhibitors: Side Effects

Few side effects are observed, and their occurrence is relatively rare.

However, the manufacturer Novartis informed in 2012 after the premature termination of the ALTITUDE study due to interim results about new recommendations for prescribing Aliskiren. According to this, it is recommended not to prescribe Aliskiren-containing medications in combination with ACE inhibitors or angiotensin receptor blockers. For patients with diabetes mellitus or renal impairment, combination therapy with Aliskiren and ACE inhibitors or angiotensin receptor blockers is contraindicated.

Renin Inhibitors: Medications/Products

The active ingredient Aliskiren is marketed under the following product names:
Rasilez, Rasilez HCT
The combination medication Rasilamo (which combined Aliskiren with a calcium antagonist) was withdrawn from the market due to insufficient benefit.

Endothelin Receptor Antagonists (ERA)

Endothelin receptor antagonists are another class of drugs for the treatment of resistant hypertension. However, most preparations are only approved for the treatment of pulmonary arterial hypertension. Only Aprocitentan received approval in the EU in 2024 for the treatment of resistant hypertension.

An endothelin receptor antagonist blocks the binding of endothelin to its receptors (ET_A and ET_B), thereby reducing the vasoconstrictive effect of endothelin. This leads to relaxation of blood vessels and a decrease in blood pressure.

Endothelin Receptor Antagonists: Side Effects

As with most medications, endothelin receptor antagonists can also have side effects. The most common include headaches, edema (fluid retention), and dizziness. It is important for patients to be regularly monitored by their doctor to detect and treat side effects early.

Sources


By Sabine Croci. This article is medically reviewed. Last updated (03/2024).
Information on the website and within the app cannot replace a consultation with a doctor, but can certainly complement it.

We hope you found the article on the topic helpful. For good blood pressure management, it is important to take the medications correctly. Our app BloodPressureDB is happy to remind you of the intake times. It also manages the supply and informs you in good time when it is running low. This feature is also fully available in the free version. Get the free app now.

afgis quality logo valid until 2024/05: Clicking the logo opens a new window with information about klier.net GmbH & Co. KG and its internet offering: www.bloodpressuredb.com/ Our offering meets the afgis transparency criteria. The afgis logo stands for high-quality health information on the internet.

Related Articles:
Search for more information about

Translation Disclaimer:
This content has been automatically translated. We strive for accuracy, but errors may occur. Please contact us if you find any inconsistencies or have questions.